We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$6.66B
AUM Growth
+$1.84B
Cap. Flow
+$1.39B
Cap. Flow %
20.91%
Top 10 Hldgs %
29.78%
Holding
2,697
New
806
Increased
729
Reduced
554
Closed
597

Sector Composition

Rank Sector Weight
1 Financials 11.66%
2 Technology 9.01%
3 Consumer Discretionary 7.23%
4 Industrials 6.92%
5 Energy 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
2076
Ocular Therapeutix
OCUL
$1.83B
$55K ﹤0.01%
+13,879
New +$48.3K
PDLI
2077
DELISTED
PDL BioPharma, Inc.
PDLI
$55K ﹤0.01%
16,983
-169,917
-91% -$493K
PFSW
2078
DELISTED
PFSweb, Inc.
PFSW
$55K ﹤0.01%
14,343
-28,844
-67% -$97.9K
NIHD
2079
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$54K ﹤0.01%
+24,935
New +$48.2K
SREV
2080
DELISTED
ServiceSource International, Inc.
SREV
$53K ﹤0.01%
31,452
-228,891
-88% -$299K
CWBR
2081
DELISTED
CohBar, Inc. Common Stock
CWBR
$45K ﹤0.01%
938
-1,627
-63% -$81.3K
UMC icon
2082
United Microelectronic
UMC
$42.9B
$44K ﹤0.01%
16,475
-41,549
-72% -$100K
MCF
2083
DELISTED
Contango Oil & Gas Co.
MCF
$44K ﹤0.01%
+12,100
New +$35.5K
CNSL
2084
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$43K ﹤0.01%
11,147
-59,253
-84% -$228K
FTSI
2085
DELISTED
FTS International, Inc. Common Stock
FTSI
$42K ﹤0.01%
2,010
+320
+19% +$8.62K
ADMS
2086
DELISTED
Adamas Pharmaceuticals
ADMS
$39K ﹤0.01%
+10,239
New +$49K
QTT
2087
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$38K ﹤0.01%
+1,103
New +$36.8K
ASRT
2088
DELISTED
Assertio
ASRT
$35K ﹤0.01%
+466
New +$27.3K
ADAP
2089
DELISTED
Adaptimmune Therapeutics
ADAP
$33K ﹤0.01%
+27,400
New +$29.2K
FINV
2090
FinVolution Group
FINV
$1.17B
$33K ﹤0.01%
+12,366
New +$32.8K
VSTM icon
2091
Verastem
VSTM
$528M
$32K ﹤0.01%
+2,003
New +$28.8K
ACRS icon
2092
Aclaris Therapeutics
ACRS
$715M
$28K ﹤0.01%
+14,650
New +$24.3K
SYBX
2093
DELISTED
Synlogic
SYBX
$28K ﹤0.01%
+735
New +$24.7K
KDNY
2094
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$27K ﹤0.01%
+4,602
New +$25K
NH
2095
DELISTED
NantHealth, Inc
NH
$25K ﹤0.01%
+1,588
New +$21.1K
RIGL icon
2096
Rigel Pharmaceuticals
RIGL
$723M
$24K ﹤0.01%
1,133
-2,077
-65% -$42.8K
BTE icon
2097
Baytex Energy
BTE
$2.96B
$16K ﹤0.01%
+11,400
New +$14.1K
ELAN icon
2098
Elanco Animal Health
ELAN
$13.2B
$1K ﹤0.01%
15,369
-99,720
-87% -$2.71M
AAL icon
2099
CALL
American Airlines Group
AAL
$9.82B
-44,000
Closed -$1.19M
AAL icon
2100
PUT
American Airlines Group
AAL
$9.82B
-45,700
Closed -$1.23M

Similar funds

Paloma Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Paloma Partners held 2,697 positions worth $6.66B, up 38% from $4.82B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Paloma Partners deployed $1.39B of net new capital in Q4 2019, opening 806 new positions and adding to 729 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 280,170 shares worth $35.9M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street Financial Select Sector SPDR ETF, an estimated $245M trimmed.

  • Paloma Partners's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 280,170 shares worth $35.9M.
  • Paloma Partners added most to State Street Energy Select Sector SPDR ETF in Q4 2019, an estimated $88.5M increase.
  • Paloma Partners's biggest Q4 2019 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $245M.
  • Paloma Partners fully exited The Southern Company in Q4 2019, selling an estimated $12.4M.
  • Paloma Partners's ten largest holdings make up 30% of its $6.66B portfolio in Q4 2019.
  • Paloma Partners opened 806 new positions and closed 597 in Q4 2019.
  • Paloma Partners's portfolio value rose 38% quarter-over-quarter to $6.66B.

Based on Paloma Partners's 13F filing for Q4 2019, filed 14 Feb 2020.